A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of machupo virus

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10995-10999

  Patterson, Michael ^a   Koma, Takaaki ^a   Seregin, Alexey ^a   Huang, Cheng ^a   Miller, Milagros ^a   Smith, Jennifer ^a   Yun, Nadezhda ^a   Smith, Jeanon ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARENAVIRUS; ARTICLE; GENETIC STABILITY; GENOTYPE; IMMUNOCOMPETENCE; KNOCKOUT MOUSE; MACHUPO ARENAVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVERSE GENETICS; VERO CELL LINE; VIRAL GENETICS; VIROGENESIS; VIRUS ATTENUATION; VIRUS MUTANT; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE; AMERICAN HEMORRHAGIC FEVER; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CELL MEMBRANE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; MOLECULAR GENETICS; NEW WORLD ARENAVIRUS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PROTEIN TERTIARY STRUCTURE; VIROLOGY; VIRULENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ARENAVIRUSES, NEW WORLD; BASE SEQUENCE; CELL MEMBRANE; GLYCOPROTEINS; HEMORRHAGIC FEVER, AMERICAN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN STRUCTURE, TERTIARY; VIRAL PROTEINS; VIRULENCE;

EID: 84906346446     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01007-14     Document Type: Article

References (41)

1. Department of Agriculture. 2012. Agricultural Bioterrorism Act of 2002. Biennial review and republication of the Select Agent and Toxin List; amendments to the Select Agent and Toxin Regulations; final rule. Fed. Regist. 77:61056-61081. http://www.gpo.gov/fdsys/pkg/FR-2012-10-05 /pdf/2012-24434.pdf.
2. Buchmeier M, de la Torre J, Peters C. 2007. Arenaviridae: the viruses and their replication, p 1791-1827. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Johnson KM. 1965. Epidemiology of Machupo virus infection. Am. J. Trop. Med. Hyg. 14:816-818.
4. Johnson KM, Wiebenga NH, Mackenzie RB, Kuns ML, Tauraso NM, Shelokov A, Webb PA, Justines G, Beye HK. 1965. Virus isolations from human cases of hemorrhagic fever in Bolivia. Proc. Soc. Exp. Biol. Med. 118:113-118. http://dx.doi.org/10.3181/00379727-118-29772.
5. Webb PA, Johnson KM, Mackenzie RB, Kuns ML. 1967. Some characteristics of Machupo virus, causative agent of Bolivian hemorrhagic fever. Am. J. Trop. Med. Hyg. 16:531-538.
6. Patterson M, Grant A, Paessler S. 2014. Epidemiology and pathogenesis of Bolivian hemorrhagic fever. Curr. Opin. Virol. 5:82-90. http://dx.doi .org/10.1016/j.coviro.2014.02.007.
7. Aguilar PV, Camargo W, Vargas J, Guevara C, Roca Y, Felices V, Laguna-Torres VA, Tesh R, Ksiazek TG, Kochel TJ. 2009. Reemergence of Bolivian hemorrhagic fever, 2007-2008. Emerg. Infect. Dis. 15:1526- 1528. http://dx.doi.org/10.3201/eid1509.090017.
8. Johnson KM, Kuns ML, Mackenzie RB, Webb PA, Yunker CE. 1966. Isolation of Machupo virus from wild rodent Calomys callosus. Am. J. Trop. Med. Hyg. 15:103-106.
9. Fulhorst CF, Bowen MD, Ksiazek TG, Rollin PE, Nichol ST, Kosoy MY, Peters CJ. 1996. Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology 224:114-120. http: //dx.doi.org/10.1006/viro.1996.0512.
10. Stinebaugh BJ, Schloeder FX, Johnson KM, Mackenzie RB, Entwisle G, De Alba E. 1966. Bolivian hemorrhagic fever: a report of four cases. Am. J. Med. 40:217-230. http://dx.doi.org/10.1016/0002-9343(66)90103-3.
11. Kilgore PE, Ksiazek TG, Rollin PE, Mills JN, Villagra MR, Montenegro MJ, Costales MA, Paredes LC, Peters CJ. 1997. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24:718- 722. http://dx.doi.org/10.1093/clind/24.4.718.
12. Peters CJ, Kuehne RW, Mercado RR, Le Bow RH, Spertzel RO, Webb PA. 1974. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am. J. Epidemiol. 99:425-433.
13. Bradfute SB, Dye JM, Jr, Bavari S. 2011. Filovirus vaccines. Hum. Vaccin. 7:701-711. http://dx.doi.org/10.4161/hv.7.6.15398.
14. Beyer WR, Pöpplau D, Garten W, von Laer D, Lenz O. 2003. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J. Virol. 77:2866-2872. http://dx.doi .org/10.1128/JVI.77.5.2866-2872.2003.
15. Lenz O, Ter Meulen J, Klenk H-D, Seidah NG, Garten W. 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad. Sci. U. S. A. 98:12701-12705. http: //dx.doi.org/10.1073/pnas.221447598.
16. York J, Nunberg JH. 2007. A novel zinc-binding domain is essential for formation of the functional Junin virus envelope glycoprotein complex. J. Virol. 81:13385-13391. http://dx.doi.org/10.1128/JVI.01785-07.
17. York J, Romanowski V, Lu M, Nunberg JH. 2004. The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J. Virol. 78:10783-10792. http://dx.doi.org/10.1128/JVI.78.19.10783-10792.2004.
18. York J, Nunberg JH. 2007. Distinct requirements for signal peptidase processing and function in the stable signal peptide subunit of the Junin virus envelope glycoprotein. Virology 359:72-81. http://dx.doi.org/10 .1016/j.virol.2006.08.048.
19. Tortorici MA, Albarino CG, Posik DM, Ghiringhelli PD, Lozano ME, Rivera Pomar R, Romanowski V. 2001. Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo. Virus Res. 73: 41-55. http://dx.doi.org/10.1016/S0168-1702(00)00222-7.
20. Meyer BJ, Southern PJ. 1994. Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic RNAs. J. Virol. 68:7659-7664.
21. Auperin DD, McCormick JB. 1989. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology 168:421-425. http://dx.doi.org/10.1016/0042-6822(89)90287-0.
22. Auperin DD, Compans RW, Bishop DHL. 1982. Nucleotide sequence conservation at the 3= termini of the virion RNA species of new World and Old World arenaviruses. Virology 121:200-203. http://dx.doi.org/10 .1016/0042-6822(82)90130-1.
23. Emonet SF, Seregin AV, Yun NE, Poussard AL, Walker AG, de la Torre JC, Paessler S. 2011. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever dis. J. Virol. 85:1473-1483. http://dx.doi.org/10.1128/JVI.02102-10.
24. Charrel RN, Lamballerie XD. 2003. Arenaviruses other than Lassa virus. Antiviral Res. 57:89-100. http://dx.doi.org/10.1016/S0166-3542(02) 00202-4.
25. American Academy of Pediatrics. 2009. Hemorrhagic fevers caused by Arenaviruses, p 325-334. In Pickering LK (ed), Red book: report of the Committee on Infectious Diseases, 28th ed. American Academy of Pediatrics, Elk Grove Village, IL.
26. Child PL, MacKenzie RB, Valverde LR, Johnson KM. 1967. Bolivian hemorrhagic fever. A pathologic description. Arch. Pathol. 83:434-445.
27. Kuns ML. 1965. Epidemiology of Machupo virus infection. Am. J. Trop. Med. Hyg. 14:813-816.
28. Acha P, Szyfres B. 2003. Machupo hemorrhagic fever, p 200-205. In Zoonoses and communicable diseases common to man and animals, 3rd ed, vol 2. Pan American Health Organization, Washington, DC.
29. Maiztegui JI, McKee KT, Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ. 1998. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J. Infect. Dis. 177:277-283. http://dx.doi.org/10.1086/514211.
30. Ambrosio AM, Riera LM, Saavedra Mdel C, Sottosanti MJ. 2005. Preclinical assay of Candid #1 vaccine against Argentine hemorrhagic fever made in Argentina. Medicina (B. Aires) 65:329-332. (In Spanish.)
31. Contigiani M, Medeot S, Diaz G. 1993. Heterogeneity and stability characteristics of Candid 1 attenuated strain of Junin virus. Acta Virol. 37:41-46.
32. Droniou-Bonzom ME, Reignier T, Oldenburg JE, Cox AU, Exline CM, Rathbun JY, Cannon PM. 2011. Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP. J. Virol. 85:13457-13462. http://dx .doi.org/10.1128/JVI.05616-11.
33. Albariño CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, Bergeron É, White DM, Nichol ST. 2011. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J. Virol. 85:10404-10408. http://dx.doi.org/10.1128/JVI.00856-11.
34. York J, Agnihothram SS, Romanowski V, Nunberg JH. 2005. Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junin arenavirus envelope glycoprotein. Virology 343:267-274. http://dx.doi .org/10.1016/j.virol.2005.08.030.
35. Agnihothram SS, York J, Trahey M, Nunberg JH. 2007. Bitopic membrane topology of the stable signal peptide in the tripartite Junin virus GP-C envelope glycoprotein complex. J. Virol. 81:4331-4337. http://dx .doi.org/10.1128/JVI.02779-06.
36. Patterson M, Seregin A, Huang C, Kolokoltsova O, Smith J, Miller M, Yun N, Poussard A, Grant A, Tigabu B, Walker A, Paessler S. 2014. Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice. J. Virol. 88:1914-1923. http://dx.doi.org/10.1128/JVI.02925-13.
37. Lukashevich IS, Patterson J, Carrion R, Moshkoff D, Ticer A, Zapata J, Brasky K, Geiger R, Hubbard GB, Bryant J, Salvato MS. 2005. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J. Virol. 79:13934-13942. http://dx.doi.org/10.1128/JVI .79.22.13934-13942.2005.
38. Lukashevich IS, Vasiuchkov AD, Stel'makh TA, Scheslenok EP, Shabanov AG. 1991. The isolation and characteristics of reassortants between the Lassa and Mopeia arenaviruses. Vopr. Virusol. 36:146-150. (In Russian.)
39. Lukashevich IS. 1992. Generation of reassortants between African arenaviruses. Virology 188:600-605. http://dx.doi.org/10.1016/0042-6822(92) 90514-P.
40. Huang C, Kolokoltsova OA, Yun NE, Seregin AV, Poussard AL, Walker AG, Brasier AR, Zhao Y, Tian B, de la Torre JC, Paessler S. 2012. Junín virus infection activates the type I interferon pathway in a RIG-Idependent manner. PLoS Negl. Trop. Dis. 6:e1659. http://dx.doi.org/10 .1371/journal.pntd.0001659.
41. Kolokoltsova OA, Yun NE, Poussard AL, Smith JK, Smith JN, Salazar M, Walker A, Tseng C-T, Aronson JF, Paessler S. 2010. Mice lacking alpha/beta and gamma interferon receptors are susceptible to Junin virus infection. J. Virol. 84:13063-13067. http://dx.doi.org/10 .1128/JVI.01389-10.